semaglutide gastric intestinal obstruction attorney in michigan legal team paralysis lawyer louisiana kentucky semaglutide intestinal paralysis semaglutide gastric intestinal obstruction law

Progress photos taken under consistent lighting conditions help visualize changes

A higher dose of Wegovy (7.2 mg) was approved by the MHRA in January 2026 following the STEP UP trial, which showed: 2 Wegovy 7.2 mg: 20.7% average weight loss Wegovy 2.4 mg: 17.5% average weight loss 50.9% of those on 7.2 mg lost at least 20% of body weight The 7.2 mg dose is not a starting dose

This is where using bacteriostatic water provides an extra layer of defense, but it doesn't make you immune to poor sterile technique

As GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro become increasingly common in both diabetes and weight loss management, a new clinical challenge is emerging: patients are reporting gastrointestinal symptoms that are difficult to differentiate from underlying disorders